Fortrea Holdings

FORTREA HOLDINGS INC

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Wall Street Cautiously Optimistic About 2025, S&P 500 Projected To Rise 9-10%: CNBC Strategist Survey

Equities

Large Cap

Market Summary

News

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Markets

Movers

Tech

ETFs

General

$BTC

$ETH

AMZN

ASTS

AVGO

BHVN

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

DAVE

SPDR Dow Jones Industrial Average ETF Trust

FTRE

GTLB

IBRX

NABL

NOVA

OKTA

RILY

SAVA

TSLA

Select Sector SPDR-Consumer Discretionary

Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February&#39;s ISM Manufacturing PMI data which fell to 50.3%, down from 50.9% in January. 

Tesla Rebounds While Tariffs Weigh On Manufacturing: What&#39;s Driving Markets Monday?

Similar Thefts Elsewhere

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

ASAN

FIVE

LULU

NCNO

ULTA

VEEV

WISA

Lululemon Athletica To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Friday

Deere & Company

Downgrades

ACDC

PCAR

This Deere Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Fortrea Holdings Inc

Small Cap

Press Releases

Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

Fortrea Holdings Inc. (FTRE) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE

Legal

Bragar Eagel & Squire, P.C. Is Investigating Fortrea and Ibotta and Encourages Investors to Contact the Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Fortrea Holdings Inc. - FTRE

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fortrea Holdings Inc. - FTRE

IBTA

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Cytek Biosciences

CryoPort

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Fortrea Holdings

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga